カテゴリ： QYResearch, 世界, 医療/バイオ

PEG-rhG-CSFの世界市場2023年：バイアル、プレフィルド

■ 英語タイトル：Global PEG-rhG-CSF Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA2996）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA2996
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[PEG-rhG-CSFの世界市場2023年：バイアル、プレフィルド]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はPEG-rhG-CSFのグローバル市場について調査・分析し、世界のPEG-rhG-CSF市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（バイアル、プレフィルド）、用途別セグメント分析（予防、治療）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Amgen、Apotex、Coherus BioSciences、Fresenius Kabi Deutschland、Juta Pharma、Mundipharma、Novartis、Pfizer、Viatris、Hengrui Pharmaceuticals、Lunan Pharmaceutical、Qilu Pharmaceutical、CSPCなどが含まれています。PEG-rhG-CSFのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、PEG-rhG-CSF市場規模を算出する際に考慮しました。

・PEG-rhG-CSF市場の概要
- 製品の定義
- PEG-rhG-CSFの種類別セグメント
- 世界のPEG-rhG-CSF市場規模：タイプ別分析（バイアル、プレフィルド）
- PEG-rhG-CSFの用途別セグメント
- 世界のPEG-rhG-CSF市場規模：用途別分析（予防、治療）
- 世界のPEG-rhG-CSF市場規模予測（2018年-2029年）
- PEG-rhG-CSFの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- PEG-rhG-CSF市場の競争状況およびトレンド

・PEG-rhG-CSFの地域別市場規模
- 北米のPEG-rhG-CSF市場規模（2018年-2029年）
- 米国のPEG-rhG-CSF市場規模（2018年-2029年）
- ヨーロッパのPEG-rhG-CSF市場規模（2018年-2029年）
- アジア太平洋のPEG-rhG-CSF市場規模（2018年-2029年）
- 中国のPEG-rhG-CSF市場規模（2018年-2029年）
- 日本のPEG-rhG-CSF市場規模（2018年-2029年）
- 韓国のPEG-rhG-CSF市場規模（2018年-2029年）
- インドのPEG-rhG-CSF市場規模（2018年-2029年）
- オーストラリアのPEG-rhG-CSF市場規模（2018年-2029年）
- 中南米のPEG-rhG-CSF市場規模（2018年-2029年）
- 中東・アフリカのPEG-rhG-CSF市場規模（2018年-2029年）

・種類別セグメント：バイアル、プレフィルド
- 世界のPEG-rhG-CSFのタイプ別販売量（2018年-2023年）
- 世界のPEG-rhG-CSFのタイプ別売上（2018年-2023年）
- 世界のPEG-rhG-CSFのタイプ別価格

・用途別セグメント：予防、治療
- 世界のPEG-rhG-CSFの用途別販売量（2018年-2023年）
- 世界のPEG-rhG-CSFの用途別売上（2018年-2023年）
- 世界のPEG-rhG-CSFの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Amgen、Apotex、Coherus BioSciences、Fresenius Kabi Deutschland、Juta Pharma、Mundipharma、Novartis、Pfizer、Viatris、Hengrui Pharmaceuticals、Lunan Pharmaceutical、Qilu Pharmaceutical、CSPC

・産業チェーンと販売チャネルの分析
- PEG-rhG-CSF産業チェーン分析
- PEG-rhG-CSFの主要原材料
- PEG-rhG-CSFの販売チャネル
- PEG-rhG-CSFのディストリビューター
- PEG-rhG-CSFの主要顧客

・PEG-rhG-CSF市場ダイナミクス
- PEG-rhG-CSFの業界動向
- PEG-rhG-CSF市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global PEG-rhG-CSF market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for PEG-rhG-CSF is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for PEG-rhG-CSF is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of PEG-rhG-CSF include Amgen, Apotex, Coherus BioSciences, Fresenius Kabi Deutschland, Juta Pharma, Mundipharma, Novartis, Pfizer and Viatris, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PEG-rhG-CSF, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEG-rhG-CSF.
The PEG-rhG-CSF market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PEG-rhG-CSF market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEG-rhG-CSF manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Amgen
Apotex
Coherus BioSciences
Fresenius Kabi Deutschland
Juta Pharma
Mundipharma
Novartis
Pfizer
Viatris
Hengrui Pharmaceuticals
Lunan Pharmaceutical
Qilu Pharmaceutical
CSPC
Segment by Type
Vials
Prefilled
Segment by Application
Prevention
Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PEG-rhG-CSF manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PEG-rhG-CSF in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 PEG-rhG-CSF Market Overview
1.1 Product Overview and Scope of PEG-rhG-CSF
1.2 PEG-rhG-CSF Segment by Type
1.2.1 Global PEG-rhG-CSF Market Value Comparison by Type (2023-2029)
1.2.2 Vials
1.2.3 Prefilled
1.3 PEG-rhG-CSF Segment by Application
1.3.1 Global PEG-rhG-CSF Market Value by Application: (2023-2029)
1.3.2 Prevention
1.3.3 Treatment
1.4 Global PEG-rhG-CSF Market Size Estimates and Forecasts
1.4.1 Global PEG-rhG-CSF Revenue 2018-2029
1.4.2 Global PEG-rhG-CSF Sales 2018-2029
1.4.3 Global PEG-rhG-CSF Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PEG-rhG-CSF Market Competition by Manufacturers
2.1 Global PEG-rhG-CSF Sales Market Share by Manufacturers (2018-2023)
2.2 Global PEG-rhG-CSF Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PEG-rhG-CSF Average Price by Manufacturers (2018-2023)
2.4 Global PEG-rhG-CSF Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of PEG-rhG-CSF, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PEG-rhG-CSF, Product Type & Application
2.7 PEG-rhG-CSF Market Competitive Situation and Trends
2.7.1 PEG-rhG-CSF Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PEG-rhG-CSF Players Market Share by Revenue
2.7.3 Global PEG-rhG-CSF Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PEG-rhG-CSF Retrospective Market Scenario by Region
3.1 Global PEG-rhG-CSF Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global PEG-rhG-CSF Global PEG-rhG-CSF Sales by Region: 2018-2029
3.2.1 Global PEG-rhG-CSF Sales by Region: 2018-2023
3.2.2 Global PEG-rhG-CSF Sales by Region: 2024-2029
3.3 Global PEG-rhG-CSF Global PEG-rhG-CSF Revenue by Region: 2018-2029
3.3.1 Global PEG-rhG-CSF Revenue by Region: 2018-2023
3.3.2 Global PEG-rhG-CSF Revenue by Region: 2024-2029
3.4 North America PEG-rhG-CSF Market Facts & Figures by Country
3.4.1 North America PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America PEG-rhG-CSF Sales by Country (2018-2029)
3.4.3 North America PEG-rhG-CSF Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PEG-rhG-CSF Market Facts & Figures by Country
3.5.1 Europe PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe PEG-rhG-CSF Sales by Country (2018-2029)
3.5.3 Europe PEG-rhG-CSF Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PEG-rhG-CSF Market Facts & Figures by Country
3.6.1 Asia Pacific PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific PEG-rhG-CSF Sales by Country (2018-2029)
3.6.3 Asia Pacific PEG-rhG-CSF Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PEG-rhG-CSF Market Facts & Figures by Country
3.7.1 Latin America PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America PEG-rhG-CSF Sales by Country (2018-2029)
3.7.3 Latin America PEG-rhG-CSF Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PEG-rhG-CSF Market Facts & Figures by Country
3.8.1 Middle East and Africa PEG-rhG-CSF Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa PEG-rhG-CSF Sales by Country (2018-2029)
3.8.3 Middle East and Africa PEG-rhG-CSF Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global PEG-rhG-CSF Sales by Type (2018-2029)
4.1.1 Global PEG-rhG-CSF Sales by Type (2018-2023)
4.1.2 Global PEG-rhG-CSF Sales by Type (2024-2029)
4.1.3 Global PEG-rhG-CSF Sales Market Share by Type (2018-2029)
4.2 Global PEG-rhG-CSF Revenue by Type (2018-2029)
4.2.1 Global PEG-rhG-CSF Revenue by Type (2018-2023)
4.2.2 Global PEG-rhG-CSF Revenue by Type (2024-2029)
4.2.3 Global PEG-rhG-CSF Revenue Market Share by Type (2018-2029)
4.3 Global PEG-rhG-CSF Price by Type (2018-2029)
5 Segment by Application
5.1 Global PEG-rhG-CSF Sales by Application (2018-2029)
5.1.1 Global PEG-rhG-CSF Sales by Application (2018-2023)
5.1.2 Global PEG-rhG-CSF Sales by Application (2024-2029)
5.1.3 Global PEG-rhG-CSF Sales Market Share by Application (2018-2029)
5.2 Global PEG-rhG-CSF Revenue by Application (2018-2029)
5.2.1 Global PEG-rhG-CSF Revenue by Application (2018-2023)
5.2.2 Global PEG-rhG-CSF Revenue by Application (2024-2029)
5.2.3 Global PEG-rhG-CSF Revenue Market Share by Application (2018-2029)
5.3 Global PEG-rhG-CSF Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amgen PEG-rhG-CSF Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Corporation Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Apotex PEG-rhG-CSF Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Coherus BioSciences
6.3.1 Coherus BioSciences Corporation Information
6.3.2 Coherus BioSciences Description and Business Overview
6.3.3 Coherus BioSciences PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Coherus BioSciences PEG-rhG-CSF Product Portfolio
6.3.5 Coherus BioSciences Recent Developments/Updates
6.4 Fresenius Kabi Deutschland
6.4.1 Fresenius Kabi Deutschland Corporation Information
6.4.2 Fresenius Kabi Deutschland Description and Business Overview
6.4.3 Fresenius Kabi Deutschland PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fresenius Kabi Deutschland PEG-rhG-CSF Product Portfolio
6.4.5 Fresenius Kabi Deutschland Recent Developments/Updates
6.5 Juta Pharma
6.5.1 Juta Pharma Corporation Information
6.5.2 Juta Pharma Description and Business Overview
6.5.3 Juta Pharma PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Juta Pharma PEG-rhG-CSF Product Portfolio
6.5.5 Juta Pharma Recent Developments/Updates
6.6 Mundipharma
6.6.1 Mundipharma Corporation Information
6.6.2 Mundipharma Description and Business Overview
6.6.3 Mundipharma PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mundipharma PEG-rhG-CSF Product Portfolio
6.6.5 Mundipharma Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis PEG-rhG-CSF Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer PEG-rhG-CSF Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Viatris
6.9.1 Viatris Corporation Information
6.9.2 Viatris Description and Business Overview
6.9.3 Viatris PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Viatris PEG-rhG-CSF Product Portfolio
6.9.5 Viatris Recent Developments/Updates
6.10 Hengrui Pharmaceuticals
6.10.1 Hengrui Pharmaceuticals Corporation Information
6.10.2 Hengrui Pharmaceuticals Description and Business Overview
6.10.3 Hengrui Pharmaceuticals PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hengrui Pharmaceuticals PEG-rhG-CSF Product Portfolio
6.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.11 Lunan Pharmaceutical
6.11.1 Lunan Pharmaceutical Corporation Information
6.11.2 Lunan Pharmaceutical PEG-rhG-CSF Description and Business Overview
6.11.3 Lunan Pharmaceutical PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Lunan Pharmaceutical PEG-rhG-CSF Product Portfolio
6.11.5 Lunan Pharmaceutical Recent Developments/Updates
6.12 Qilu Pharmaceutical
6.12.1 Qilu Pharmaceutical Corporation Information
6.12.2 Qilu Pharmaceutical PEG-rhG-CSF Description and Business Overview
6.12.3 Qilu Pharmaceutical PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Qilu Pharmaceutical PEG-rhG-CSF Product Portfolio
6.12.5 Qilu Pharmaceutical Recent Developments/Updates
6.13 CSPC
6.13.1 CSPC Corporation Information
6.13.2 CSPC PEG-rhG-CSF Description and Business Overview
6.13.3 CSPC PEG-rhG-CSF Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CSPC PEG-rhG-CSF Product Portfolio
6.13.5 CSPC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PEG-rhG-CSF Industry Chain Analysis
7.2 PEG-rhG-CSF Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PEG-rhG-CSF Production Mode & Process
7.4 PEG-rhG-CSF Sales and Marketing
7.4.1 PEG-rhG-CSF Sales Channels
7.4.2 PEG-rhG-CSF Distributors
7.5 PEG-rhG-CSF Customers
8 PEG-rhG-CSF Market Dynamics
8.1 PEG-rhG-CSF Industry Trends
8.2 PEG-rhG-CSF Market Drivers
8.3 PEG-rhG-CSF Market Challenges
8.4 PEG-rhG-CSF Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global PEG-rhG-CSF Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global PEG-rhG-CSF Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global PEG-rhG-CSF Market Competitive Situation by Manufacturers in 2022
Table 4. Global PEG-rhG-CSF Sales (K L) of Key Manufacturers (2018-2023)
Table 5. Global PEG-rhG-CSF Sales Market Share by Manufacturers (2018-2023)
Table 6. Global PEG-rhG-CSF Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global PEG-rhG-CSF Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market PEG-rhG-CSF Average Price (US$/L) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of PEG-rhG-CSF, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of PEG-rhG-CSF, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PEG-rhG-CSF, Product Type & Application
Table 12. Global Key Manufacturers of PEG-rhG-CSF, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PEG-rhG-CSF by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEG-rhG-CSF as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PEG-rhG-CSF Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global PEG-rhG-CSF Sales by Region (2018-2023) & (K L)
Table 18. Global PEG-rhG-CSF Sales Market Share by Region (2018-2023)
Table 19. Global PEG-rhG-CSF Sales by Region (2024-2029) & (K L)
Table 20. Global PEG-rhG-CSF Sales Market Share by Region (2024-2029)
Table 21. Global PEG-rhG-CSF Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global PEG-rhG-CSF Revenue Market Share by Region (2018-2023)
Table 23. Global PEG-rhG-CSF Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global PEG-rhG-CSF Revenue Market Share by Region (2024-2029)
Table 25. North America PEG-rhG-CSF Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America PEG-rhG-CSF Sales by Country (2018-2023) & (K L)
Table 27. North America PEG-rhG-CSF Sales by Country (2024-2029) & (K L)
Table 28. North America PEG-rhG-CSF Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America PEG-rhG-CSF Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe PEG-rhG-CSF Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe PEG-rhG-CSF Sales by Country (2018-2023) & (K L)
Table 32. Europe PEG-rhG-CSF Sales by Country (2024-2029) & (K L)
Table 33. Europe PEG-rhG-CSF Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe PEG-rhG-CSF Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific PEG-rhG-CSF Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific PEG-rhG-CSF Sales by Region (2018-2023) & (K L)
Table 37. Asia Pacific PEG-rhG-CSF Sales by Region (2024-2029) & (K L)
Table 38. Asia Pacific PEG-rhG-CSF Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific PEG-rhG-CSF Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America PEG-rhG-CSF Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America PEG-rhG-CSF Sales by Country (2018-2023) & (K L)
Table 42. Latin America PEG-rhG-CSF Sales by Country (2024-2029) & (K L)
Table 43. Latin America PEG-rhG-CSF Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America PEG-rhG-CSF Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa PEG-rhG-CSF Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa PEG-rhG-CSF Sales by Country (2018-2023) & (K L)
Table 47. Middle East & Africa PEG-rhG-CSF Sales by Country (2024-2029) & (K L)
Table 48. Middle East & Africa PEG-rhG-CSF Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa PEG-rhG-CSF Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global PEG-rhG-CSF Sales (K L) by Type (2018-2023)
Table 51. Global PEG-rhG-CSF Sales (K L) by Type (2024-2029)
Table 52. Global PEG-rhG-CSF Sales Market Share by Type (2018-2023)
Table 53. Global PEG-rhG-CSF Sales Market Share by Type (2024-2029)
Table 54. Global PEG-rhG-CSF Revenue (US$ Million) by Type (2018-2023)
Table 55. Global PEG-rhG-CSF Revenue (US$ Million) by Type (2024-2029)
Table 56. Global PEG-rhG-CSF Revenue Market Share by Type (2018-2023)
Table 57. Global PEG-rhG-CSF Revenue Market Share by Type (2024-2029)
Table 58. Global PEG-rhG-CSF Price (US$/L) by Type (2018-2023)
Table 59. Global PEG-rhG-CSF Price (US$/L) by Type (2024-2029)
Table 60. Global PEG-rhG-CSF Sales (K L) by Application (2018-2023)
Table 61. Global PEG-rhG-CSF Sales (K L) by Application (2024-2029)
Table 62. Global PEG-rhG-CSF Sales Market Share by Application (2018-2023)
Table 63. Global PEG-rhG-CSF Sales Market Share by Application (2024-2029)
Table 64. Global PEG-rhG-CSF Revenue (US$ Million) by Application (2018-2023)
Table 65. Global PEG-rhG-CSF Revenue (US$ Million) by Application (2024-2029)
Table 66. Global PEG-rhG-CSF Revenue Market Share by Application (2018-2023)
Table 67. Global PEG-rhG-CSF Revenue Market Share by Application (2024-2029)
Table 68. Global PEG-rhG-CSF Price (US$/L) by Application (2018-2023)
Table 69. Global PEG-rhG-CSF Price (US$/L) by Application (2024-2029)
Table 70. Amgen Corporation Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 73. Amgen PEG-rhG-CSF Product
Table 74. Amgen Recent Developments/Updates
Table 75. Apotex Corporation Information
Table 76. Apotex Description and Business Overview
Table 77. Apotex PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 78. Apotex PEG-rhG-CSF Product
Table 79. Apotex Recent Developments/Updates
Table 80. Coherus BioSciences Corporation Information
Table 81. Coherus BioSciences Description and Business Overview
Table 82. Coherus BioSciences PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 83. Coherus BioSciences PEG-rhG-CSF Product
Table 84. Coherus BioSciences Recent Developments/Updates
Table 85. Fresenius Kabi Deutschland Corporation Information
Table 86. Fresenius Kabi Deutschland Description and Business Overview
Table 87. Fresenius Kabi Deutschland PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 88. Fresenius Kabi Deutschland PEG-rhG-CSF Product
Table 89. Fresenius Kabi Deutschland Recent Developments/Updates
Table 90. Juta Pharma Corporation Information
Table 91. Juta Pharma Description and Business Overview
Table 92. Juta Pharma PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 93. Juta Pharma PEG-rhG-CSF Product
Table 94. Juta Pharma Recent Developments/Updates
Table 95. Mundipharma Corporation Information
Table 96. Mundipharma Description and Business Overview
Table 97. Mundipharma PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 98. Mundipharma PEG-rhG-CSF Product
Table 99. Mundipharma Recent Developments/Updates
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 103. Novartis PEG-rhG-CSF Product
Table 104. Novartis Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 108. Pfizer PEG-rhG-CSF Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Viatris Corporation Information
Table 111. Viatris Description and Business Overview
Table 112. Viatris PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 113. Viatris PEG-rhG-CSF Product
Table 114. Viatris Recent Developments/Updates
Table 115. Hengrui Pharmaceuticals Corporation Information
Table 116. Hengrui Pharmaceuticals Description and Business Overview
Table 117. Hengrui Pharmaceuticals PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 118. Hengrui Pharmaceuticals PEG-rhG-CSF Product
Table 119. Hengrui Pharmaceuticals Recent Developments/Updates
Table 120. Lunan Pharmaceutical Corporation Information
Table 121. Lunan Pharmaceutical Description and Business Overview
Table 122. Lunan Pharmaceutical PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 123. Lunan Pharmaceutical PEG-rhG-CSF Product
Table 124. Lunan Pharmaceutical Recent Developments/Updates
Table 125. Qilu Pharmaceutical Corporation Information
Table 126. Qilu Pharmaceutical Description and Business Overview
Table 127. Qilu Pharmaceutical PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 128. Qilu Pharmaceutical PEG-rhG-CSF Product
Table 129. Qilu Pharmaceutical Recent Developments/Updates
Table 130. CSPC Corporation Information
Table 131. CSPC Description and Business Overview
Table 132. CSPC PEG-rhG-CSF Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 133. CSPC PEG-rhG-CSF Product
Table 134. CSPC Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. PEG-rhG-CSF Distributors List
Table 138. PEG-rhG-CSF Customers List
Table 139. PEG-rhG-CSF Market Trends
Table 140. PEG-rhG-CSF Market Drivers
Table 141. PEG-rhG-CSF Market Challenges
Table 142. PEG-rhG-CSF Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PEG-rhG-CSF
Figure 2. Global PEG-rhG-CSF Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global PEG-rhG-CSF Market Share by Type in 2022 & 2029
Figure 4. Vials Product Picture
Figure 5. Prefilled Product Picture
Figure 6. Global PEG-rhG-CSF Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global PEG-rhG-CSF Market Share by Application in 2022 & 2029
Figure 8. Prevention
Figure 9. Treatment
Figure 10. Global PEG-rhG-CSF Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global PEG-rhG-CSF Market Size (2018-2029) & (US$ Million)
Figure 12. Global PEG-rhG-CSF Sales (2018-2029) & (K L)
Figure 13. Global PEG-rhG-CSF Average Price (US$/L) & (2018-2029)
Figure 14. PEG-rhG-CSF Report Years Considered
Figure 15. PEG-rhG-CSF Sales Share by Manufacturers in 2022
Figure 16. Global PEG-rhG-CSF Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest PEG-rhG-CSF Players: Market Share by Revenue in 2022
Figure 18. PEG-rhG-CSF Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global PEG-rhG-CSF Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America PEG-rhG-CSF Sales Market Share by Country (2018-2029)
Figure 21. North America PEG-rhG-CSF Revenue Market Share by Country (2018-2029)
Figure 22. U.S. PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe PEG-rhG-CSF Sales Market Share by Country (2018-2029)
Figure 25. Europe PEG-rhG-CSF Revenue Market Share by Country (2018-2029)
Figure 26. Germany PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific PEG-rhG-CSF Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific PEG-rhG-CSF Revenue Market Share by Region (2018-2029)
Figure 33. China PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Taiwan PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Philippines PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America PEG-rhG-CSF Sales Market Share by Country (2018-2029)
Figure 44. Latin America PEG-rhG-CSF Revenue Market Share by Country (2018-2029)
Figure 45. Mexico PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa PEG-rhG-CSF Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa PEG-rhG-CSF Revenue Market Share by Country (2018-2029)
Figure 50. Turkey PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. U.A.E PEG-rhG-CSF Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of PEG-rhG-CSF by Type (2018-2029)
Figure 54. Global Revenue Market Share of PEG-rhG-CSF by Type (2018-2029)
Figure 55. Global PEG-rhG-CSF Price (US$/L) by Type (2018-2029)
Figure 56. Global Sales Market Share of PEG-rhG-CSF by Application (2018-2029)
Figure 57. Global Revenue Market Share of PEG-rhG-CSF by Application (2018-2029)
Figure 58. Global PEG-rhG-CSF Price (US$/L) by Application (2018-2029)
Figure 59. PEG-rhG-CSF Value Chain
Figure 60. PEG-rhG-CSF Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 組換えヒト顆粒球コロニー刺激因子注射（rhG-CSF）の世界市場2023年：バイアル、プレフィルド
  • アダゲンのグローバル市場展望 2023年-2029年：プレフィルド、バイアル
  • ペガデマーゼウシのグローバル市場展望 2023年-2029年：プレフィルド、バイアル
  • ペガデマーゼウシ薬のグローバル市場展望 2023年-2029年：プレフィルド、バイアル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA2996 )"PEG-rhG-CSFの世界市場2023年：バイアル、プレフィルド" (英文：Global PEG-rhG-CSF Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。